The Daily Fuckup

The Drug Enforcement Administration began formal hearing proceedings on June 29, 2026, over a proposed rule that would move marijuana from Schedule I to Schedule III under the Controlled Substances Act. The hearing is part of the Justice Department’s administrative rulemaking process and follows earlier notices and filings laying out how the agency plans to handle the rescheduling proposal.

The proposal matters because the federal scheduling status of marijuana affects how the drug is regulated across research, medical use, criminal enforcement, and commerce. A move from Schedule I to Schedule III would not legalize marijuana under federal law, but it would represent a significant change in how the government classifies the substance and administers its rules.

The June 29 hearing is procedural, but it is still a meaningful step. DEA said the proceeding will give participants a formal venue to present evidence and arguments on the proposed change. The agency has also published related materials describing the rescheduling process and the preliminary order that set the hearing in motion.

For states, businesses, patients, and researchers, the point is not just whether the government is reconsidering marijuana’s status. It is how slowly and through what channels that reconsideration will move. The hearing does not settle the question. It starts the record that will shape the outcome.